Skip to content
Future Direct

The Zimbabwean Government Turns Down ‘Lopsided’ American Healthcare Assistance Package Because of Information Concerns

Medical funding image
The proposed US funding was intended for initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has declined a major US healthcare agreement valued at $367m (272 million pounds) spanning five years over the United States' demand for sensitive data.

This move became public after a internal memorandum from December was disclosed, indicating that President Emmerson Mnangagwa believed the deal was "skewed".

A government spokesperson later clarified that the US was demanding access to biological samples for research and commercial gain but was unwilling to share the resulting advantages from any future vaccines.

"We must now begin the difficult and regrettable task of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has called for further negotiations to reach a deal agreeable to both sides so the nation's vital HIV treatment initiative can proceed.

Broader Background

This development comes after a similar case in neighbouring Kenya, where a high court halted a similar health funding agreement after legal challenges were raised about the security of Kenyans' medical information.

After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had managed assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government agreements to boost openness and accountability.

As per reports, 16 African countries have so far signed these new health pacts, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Deal

The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this partnership might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana said the arrangement was "unfair".

"Our nation was requested to provide its genetic material and health information for a long time, without any equivalent guarantee of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.

"Effectively, our nation would supply the basic resources for medical research with no assurance that the end products would be accessible to our citizens should a new disease outbreak emerge."

National Interest and Global Health

He also noted that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting systems previously established through the global health agency.

Mangwana cited its Pandemic Benefit-Sharing system created to manage future pandemics.

"This system is designed to ensure that when a nation contributes its data, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to develop them."

The government's concerns over the US deal "must not be interpreted as opposition to America," he added.

"We encourage ongoing discussions with our US partners on how subsequent co-operation might be structured in a manner that honours the independence and interests of both nations."

Medical Community Response

Medical experts expressed it recognised the government's concerns, but suggested that negotiations should continue considering much of the nation's HIV programmes were funded by foreign aid.

"In cases where specific concerns arise, including those relating to data governance or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," the group said.

The halted deal underscores the complex challenges between receiving vital foreign assistance and protecting a country's data in an ever more data-driven world.

JM
Written by

Jillian Murphy

A tech journalist and digital strategist with over a decade of experience covering emerging technologies and their impact on society.

Future Direct

Type to search articles.